OTCMKTS:INSV InSite Vision (INSV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About InSite Vision Stock (OTCMKTS:INSV) Get InSite Vision alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume650,138 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview InSite Vision, Inc. is a development‐stage in‐vitro diagnostics company specializing in rapid molecular assays for infectious ocular diseases. The company’s core focus is on leveraging real‐time polymerase chain reaction (PCR) technology to detect bacterial pathogens responsible for eye infections, with an emphasis on delivering timely, actionable results to clinicians. The company’s lead products include CE-marked real-time PCR assays designed to differentiate between Chlamydia trachomatis and Neisseria gonorrhoeae in ocular specimens. These assays are engineered for integration into standard laboratory workflows, enabling clinical laboratories and ophthalmology clinics to streamline pathogen identification and support more targeted treatment decisions. Headquartered in Alameda, California, InSite Vision served markets in North America and Europe through a combination of direct sales efforts and distributor partnerships. The company pursued regulatory clearances in key geographies and collaborated with clinical laboratories, hospitals, and ophthalmic practices to facilitate the adoption of its diagnostic platforms. Founded in 1992, InSite Vision assembled a leadership team with extensive expertise in molecular diagnostics and ophthalmic testing. In April 2014, the company was acquired by Becton Dickinson, a strategic move that integrated InSite Vision’s molecular platforms into BD’s broader portfolio of point‐of‐care diagnostic solutions and expanded the reach of its technologies within clinical settings.AI Generated. May Contain Errors. Read More Receive INSV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InSite Vision and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSV Stock News HeadlinesReviewing iBio (NYSE:IBIO) and InSite Vision (OTCMKTS:INSV)September 30, 2025 | americanbankingnews.com2024 Computer Vision Insights: AI, Healthcare, Retail, and Surveillance TrendsSeptember 18, 2024 | msn.comTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.October 6 at 2:00 AM | Stansberry Research (Ad)Disney+ Launches Nat Geo Immersive Environment for Apple Vision ProAugust 7, 2024 | msn.comNew model shows cortical implants like Elon Musk's Blindsight are unlikely to 'exceed normal human vision'July 29, 2024 | msn.comQ4 2023 Streamline Health Solutions Inc Earnings CallApril 30, 2024 | finance.yahoo.comInnovative Features Making the Ulike Air 10 Superior to the Previous ModelsApril 30, 2024 | msn.comRumors swirl that Apple plan to use ChatGPT to power AI features in iOS 18April 29, 2024 | msn.comSee More Headlines INSV Stock Analysis - Frequently Asked Questions How do I buy shares of InSite Vision? Shares of INSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InSite Vision own? Based on aggregate information from My MarketBeat watchlists, some other companies that InSite Vision investors own include Aralez Pharmaceuticals (ARLZ), Novelion Therapeutics (NVLN), Portola Pharmaceuticals (PTLA), Porsche Automobil (POAHY), MannKind (MNKD), Liquidia Technologies (LQDA) and iBio (IBIO). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorManufacturing Industry Pharmaceutical Preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:INSV CIK802724 Webwww.insitevision.com Phone+1-510-8658800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (OTCMKTS:INSV) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InSite Vision Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share InSite Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.